Bio-Techne (TECH) Cash from Investing Activities (2016 - 2026)
Bio-Techne has reported Cash from Investing Activities over the past 17 years, most recently at -$5.9 million for Q4 2025.
- For Q4 2025, Cash from Investing Activities fell 17.67% year-over-year to -$5.9 million; the TTM value through Dec 2025 reached -$13.8 million, up 73.48%, while the annual FY2025 figure was -$35.2 million, 82.67% up from the prior year.
- Cash from Investing Activities for Q4 2025 was -$5.9 million at Bio-Techne, down from $605000.0 in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $605000.0 in Q3 2025 and troughed at -$241.1 million in Q1 2023.
- A 5-year average of -$41.6 million and a median of -$12.7 million in 2024 define the central range for Cash from Investing Activities.
- Biggest five-year swings in Cash from Investing Activities: tumbled 28001.55% in 2022 and later soared 104.61% in 2025.
- Year by year, Cash from Investing Activities stood at -$35.2 million in 2021, then skyrocketed by 99.69% to -$109000.0 in 2022, then crashed by 21616.51% to -$23.7 million in 2023, then skyrocketed by 78.74% to -$5.0 million in 2024, then decreased by 17.67% to -$5.9 million in 2025.
- Business Quant data shows Cash from Investing Activities for TECH at -$5.9 million in Q4 2025, $605000.0 in Q3 2025, and $406000.0 in Q2 2025.